The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy
- PMID: 31506885
- DOI: 10.1007/s11936-019-0750-3
The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy
Abstract
Purpose of review: A multidisciplinary approach is vital to reduce mortality and hospitalizations in patients with heart failure. As members of the multidisciplinary team, pharmacists are uniquely positioned to care for patients across the spectrum of heart failure. This comprehensive review explores the different facets in which pharmacists can be utilized to impact the care for patients with heart failure, including those with cardiac transplant and left ventricular assist devices (LVADs), in the outpatient setting.
Recent findings: Pharmacists can see heart failure patients in a variety of settings to reduce drug therapy-related issues, increase use of guideline-directed medical therapy (GDMT), and reduce hospitalizations. Although there is limited data available, pharmacists have also been described in aiding the therapeutic drug monitoring of warfarin for patients with LVADs and immunosuppression agents in the transplant population. Through collaborative practice agreements, pharmacists can provide progressive services such as titration of GDMT and lab monitoring, in addition to medication reconciliation, education, and review for potential drug-related problems. Pharmacists can increase access to patient care by providing services through distance-visits, shared medical appointments, and home visits.
Keywords: Heart failure; Outpatient therapy; Pharmacist-based services.
Similar articles
-
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.J Card Fail. 2013 May;19(5):354-69. doi: 10.1016/j.cardfail.2013.02.002. Epub 2013 Apr 6. J Card Fail. 2013. PMID: 23663818
-
Evaluating Pharmacist Impact on Guideline-Directed Medical Therapy in Patients With Reduced Ejection Fraction Heart Failure.J Pharm Pract. 2021 Apr;34(2):239-246. doi: 10.1177/0897190019866930. Epub 2019 Aug 11. J Pharm Pract. 2021. PMID: 31401924
-
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.Pharmacotherapy. 2013 May;33(5):529-48. doi: 10.1002/phar.1295. Pharmacotherapy. 2013. PMID: 23649813
-
Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.J Clin Pharm Ther. 2007 Aug;32(4):343-52. doi: 10.1111/j.1365-2710.2007.00827.x. J Clin Pharm Ther. 2007. PMID: 17635336 Review.
-
Treatment Considerations and the Role of the Clinical Pharmacist Throughout Transitions of Care for Patients With Acute Heart Failure.J Pharm Pract. 2017 Aug;30(4):441-450. doi: 10.1177/0897190016645435. Epub 2016 Apr 28. J Pharm Pract. 2017. PMID: 27129914 Free PMC article. Review.
Cited by
-
Rationale and design of a navigator-driven remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.Clin Cardiol. 2020 Jan;43(1):4-13. doi: 10.1002/clc.23291. Epub 2019 Nov 14. Clin Cardiol. 2020. PMID: 31725920 Free PMC article.
-
Utilizing Pharmacist-Led Telehealth Services in Ambulatory Patients with Heart Failure.Innov Pharm. 2023 Oct 10;14(1):10.24926/iip.v14i1.5306. doi: 10.24926/iip.v14i1.5306. eCollection 2023. Innov Pharm. 2023. PMID: 38035317 Free PMC article.
-
Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study.BMC Cardiovasc Disord. 2022 Sep 19;22(1):418. doi: 10.1186/s12872-022-02859-4. BMC Cardiovasc Disord. 2022. PMID: 36123632 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous